chavallo67
Nuovo Utente
- Registrato
- 16/3/05
- Messaggi
- 12.572
- Punti reazioni
- 284
Alla ricerca della peggio ciofeca 
Market Cap 23.50M
Employees 11
Short Float 9.81%
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing pharmaceutical therapies for treating oncology and endocrinology. Its commercial product is the Macrilen, a ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a, a ghrelin receptor, which is used for endocrinology and oncology indications. The company has a license and assignment agreement with Strongbridge Ireland Limited for the development, manufacturing, registration, and commercialization of Macrilen in the United States and Canada. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.
UPCOMING EVENTS
H.C. Wainwright 22nd Annual Global Investment Conference
Wednesday, September 16, 2020 11:00 AM EDT
Market Cap 23.50M
Employees 11
Short Float 9.81%
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing pharmaceutical therapies for treating oncology and endocrinology. Its commercial product is the Macrilen, a ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a, a ghrelin receptor, which is used for endocrinology and oncology indications. The company has a license and assignment agreement with Strongbridge Ireland Limited for the development, manufacturing, registration, and commercialization of Macrilen in the United States and Canada. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.
UPCOMING EVENTS
H.C. Wainwright 22nd Annual Global Investment Conference
Wednesday, September 16, 2020 11:00 AM EDT
Ultima modifica: